William Lopez remembers clearly the day in June 2017 when he says he was asked to call the spouse of a college friend who had just died and ask for her eyes.
Cour Pharmaceuticals, a biotech taking aim at autoimmune diseases, raises $105 million
John Puisis was dubious when he first heard about the autoimmune science being developed by a coalition of scientists from Northwestern University and the University
January 30, 2024